Caution Urged As FDA Works to Improve Safe Prescription-Opioid Use
Fri, 31 Oct 2014 00:00:00 -0400
FDA this week heard from the public on the agency's efforts to improve the safe use of prescription opioids for pain treatment through the adoption of abuse-deterrent formulations.
FDA Approves Vaccine to Prevent Serogroup B Meningococcal Disease
Thu, 30 Oct 2014 00:00:00 -0400
FDA and Pfizer Inc. on Wednesday announced the approval of meningococcal group B vaccine, or Trumenba, for the active immunization of persons 10–25 years old to prevent invasive disease caused by Neisseria meningitidis serogroup B.
Investigational Drug Services Aid Ebola Response
Tue, 28 Oct 2014 00:00:00 -0400
The handful of U.S. cases of Ebola virus disease
(EVD) have cast investigational drug therapy into the national spotlight and
brought attention to this area of pharmacy practice.
FDA Approves Recombinant Porcine-Sequence Factor VIII
Fri, 24 Oct 2014 00:00:00 -0400
FDA on October 23 approved recombinant porcine-sequence antihemophilic factor, or Obizur, for the treatment of bleeding episodes in adults with acquired hemophilia A.
Hospira Recalls Dozens of Product Lots
Thu, 23 Oct 2014 00:00:00 -0400
Hospira recently announced the recall of one lot of lidocaine hydrochloride injection (PDF) and multiple lots of 12 injectable products packaged in flexible i.v. containers (PDF) .